Table 1.
Patients | Age | Sex | CSF Titer | Amylin | Aβ38 | Aβ40 | Aβ42 | Thio-T |
---|---|---|---|---|---|---|---|---|
(Anti-VZV IgG) | (pM) | (pg/mL) | (pg/mL) | (pg/mL) | (AU) | |||
VZV-negative controls with stroke | ||||||||
C1 | 64 | M | 0.199 | 6.18 | 595.97 | 1950.28 | 95.28 | 387.67 |
C2 | 59 | F | 0.144 | 8 | 1448.48 | 4911.59 | 275.22 | 1671.17 |
C3 | 37 | F | 0.076 | 7.04 | 435.9 | 1110.21 | 39.09 | NM |
C4 | 44 | M | 0.0075 | 4.98 | 1831.39 | 5349.71 | 398.13 | 257.67 |
C5 | 66 | F | 0.041 | 3.74 | 1451.63 | 4335.91 | 178.18 | 542.17 |
C6 | 68 | F | 0.105 | 8.46 | 731.35 | 2120.36 | 98.94 | 207.17 |
C7 | 26 | M | 0.064 | 4.84 | 673.24 | 2100.46 | 133.24 | 420.17 |
C8 | 49 | M | 0.023 | 3.92 | 998.22 | 2606.64 | 98.94 | 931.67 |
C9 | 51 | M | 0.001 | 7.68 | 639.8 | 2080.94 | 100.74 | 468.67 |
C10 | 22 | M | 0.18 | 7.79 | 522.58 | 1847.46 | 99.89 | 126.67 |
C11 | 78 | M | 0.09 | 3.32 | 1189.16 | 2781.59 | 129.32 | 521.17 |
C12 | 74 | M | 0.031 | 2.16 | 1366.34 | 4166.68 | 268.47 | 684.17 |
C13 | 46 | F | 0.053 | 8.22 | 954.99 | 2841.99 | 146.65 | 378.17 |
C14 | 22 | M | 0.156 | 7.95 | 730.67 | 2397.42 | 100.74 | 352.67 |
C15 | 53 | M | 0.035 | 4.31 | 1011.4 | 3212.61 | 158.55 | 347.17 |
C16 | 69 | F | 0.09 | 3.08 | 1143.01 | 3325.35 | 130.67 | 602.67 |
C17 | 50 | F | 0.142 | 6.14 | 1020.09 | 3039.5 | 152.29 | NM |
C18 | 44 | F | 0.195 | 7.78 | 724.59 | 2435.08 | 124.9 | 564.17 |
C19 | 65 | M | 0.01 | 4.18 | 294.5 | 787.92 | 23.81 | 637.17 |
C20 | 19 | F | 0.0115 | 4.39 | 770.33 | 2538.79 | 142.29 | 445.67 |
C21 | 72 | F | 0.091 | 10.61 | 691.75 | 1824.28 | 33.34 | 491.67 |
C22 | 45 | F | 0.015 | 8.83 | 607.69 | 2031.7 | 73.63 | 111.67 |
C23 | 42 | F | 0.0045 | 5.01 | 1459.22 | 4987.08 | 268.13 | 901.67 |
C24 | 45 | M | 0.025 | 5.03 | 897.2 | 3072.38 | 175.86 | 1106.67 |
C25 | 77 | M | 0.06 | 9.13 | 1116.97 | 3198.6 | 174.48 | 419.17 |
C26 | 35 | M | 0.07 | 9.24 | 663.41 | 2442.31 | 129.08 | 507.67 |
C27 | 70 | M | 0.06 | 5.24 | 1101.85 | 3787.31 | 114.09 | 926.67 |
C28 | 59 | F | 0.007 | 6.11 | 1880.93 | 6026.7 | 451.55 | 454.67 |
C29 | 45 | M | 0.008 | 11.89 | 577.01 | 2115 | 115.26 | 1294.67 |
C30 | 58 | M | 0.09 | 9.67 | 756.65 | 2908.09 | 125.25 | 963.17 |
C31 | 53 | F | 0.07 | 8.73 | 1099.1 | 4492.33 | 257.36 | 708.17 |
C32 | 44 | F | 0.03 | 9.99 | 561.81 | 2134.43 | 103.58 | 54.67 |
C33 | 35 | M | 0.035 | 12.93 | 1524.07 | 5865.8 | 329.37 | 291.67 |
C34 | 72 | F | 0.09 | 11.23 | 851.85 | 3094.72 | 116.77 | 535.17 |
C35 | 62 | M | 0.07 | 12.21 | 499.88 | 1800.62 | 75.88 | 253.17 |
C36 | 59 | F | 0.0075 | 13.55 | 1488.71 | 4677.27 | 277.31 | 421.67 |
VZV-positive subjects with vasculopathy | ||||||||
V1 | 53 | M | 4.11 | 12 | 570.61 | 1150.09 | 138.79 | 1808 |
V2 | 44 | F | 4.8155 | 12.25 | 380.01 | 977.47 | 84.92 | 4135 |
V3 | 55 | M | 0.73 | 12.58 | 602.03 | 1724.07 | 191.49 | 1361 |
V4 | 33 | M | 0.35 | 11.13 | 428.26 | 1055.4 | 99.35 | 1143 |
V5 | 45 | M | 1.048 | 11.33 | 131.52 | 392.68 | 24.82 | 2216 |
V6 | 54 | F | 0.65 | 11.16 | 1474.15 | 2695.44 | 269.29 | 1126.5 |
V7 | 33 | M | 0.297 | 7.857 | 618.03 | 1285.3 | 142.35 | 844.25 |
V8 | 27 | F | 0.819 | 9.433 | 246.42 | 751.55 | 47.91 | 591.25 |
V9 | 62 | M | 1.843 | 9.231 | 298.52 | 939 | 98.78 | 1037 |
V10 | 79 | F | 0.213 | 11.05 | 575.75 | 1517.54 | 85 | 649.25 |
V11 | 75 | M | 2.43 | 8.649 | 345.7 | 926.57 | 61.54 | 1831.75 |
V12 | 65 | M | 3.7 | 7.439 | 772.39 | 1809.11 | 220.22 | 1430.75 |
V13 | 78 | F | 3.29 | 9.049 | 922.93 | 2190.95 | 293.65 | 536.25 |
V14 | 60 | M | 1.07 | 7.91 | 429.8 | 1130.73 | 62.4 | 1229.25 |
V15 | 60 | F | 1.1375 | 8.431 | 1377.54 | 2211.27 | 406.36 | 2633.25 |
V16 | 48 | M | 5.41 | NM | 2219.88 | 3987.74 | 543.44 | 2741.25 |
Abbreviations: AU, artificial units; CSF, cerebrospinal fluid; F, female; IgG, immunoglobulin G; M, male; NM, not measured; VZV, varicella zoster virus.